MARC Record from Library of Congress

LEADER: 01694nam a22003858a 4500
001 2008003218
003 DLC
005 20080128080823.0
008 080123s2008 flu 000 0 eng
035 $a(DNLM)101464424
010 $a 2008003218
020 $a9781599424446 (pbk. : alk. paper)
020 $a1599424444 (pbk. : alk. paper)
040 $aDNLM/DLC$cDLC$dDLC
042 $apcc
050 00 $aKF3894.G45$bV64 2008
060 10 $aQV 33 AA1$bV876g 2008
082 00 $a346.7304/86$222
100 1 $aVoet, Martin A.,$d1942-
245 14 $aThe generic challenge :$bunderstanding patents, FDA & pharmaceutical life-cycle management /$cMartin A. Voet.
250 $a2nd ed.
260 $aBoca Raton :$bBrownWalker Press,$c2008.
263 $a0803
300 $ap. ;$ccm.
505 0 $aOverview of patents -- Patent enforcement and infringement -- Pharmaceutical, biological, and medical device patents -- Overview of FDA -- Drug product exclusivity -- Hatch Waxman Act -- Putting it all together: product life-cyclemanagement -- Conclusions and final thoughts.
650 0 $aDrugs$xGeneric substitution$xLaw and legislation$zUnited States.
650 0 $aDrugs$zUnited States$xGeneric substitution$xPatents.
650 0 $aPatent extensions$zUnited States.
650 0 $aPharmaceutical biotechnology$xPatents.
650 0 $aPharmaceutical biotechnology$xLaw and legislation.
650 12 $aDrugs, Generic$xeconomics$zUnited States.
650 12 $aLegislation, Drug$zUnited States.
650 22 $aDrug Industry$xeconomics$zUnited States.
650 22 $aDrug Industry$xlegislation & jurisprudence$zUnited States.
650 22 $aPatents as Topic$xlegislation & jurisprudence$zUnited States.